Below content

GeoPolitics Pulse

  • Middle East
    • Israel
    • Lebanon
    • Qatar
    • Saudi Arabia
    • Syria
    • Iraq
    • Iran
    • Turkey
  • Russia
    • Armenia
  • Asia
    • India
    • China
    • Taiwan
    • Singapore
    • Japan
    • North Korea
    • South Korea
  • Africa
  • Western Europe
    • European union
    • Germany
    • Italy
    • United Kingdom
    • France
  • Eastern Europe
    • Czechia
    • Slovakia
    • Poland
    • Hungary
    • Romania
    • Ukraine
  • America
  • Finance
    • Gold
    • Global Debt
    • BRICS
    • World Economic Forum
  • Technology
    • Amazon
    • Starbucks
    • Tesla
    • Nvidia
    • Instagram
    • Meta
    • Microsoft
    • Google
    • ChatGPT
    • Artificial Intelligence
    • Apple
    • Transhumanism
  • Australia

GeoPolitics Pulse

The Heartbeat of World events

  • Middle East
    • Israel
    • Lebanon
    • Qatar
    • Saudi Arabia
    • Syria
    • Iraq
    • Iran
    • Turkey
  • Russia
    • Armenia
  • Asia
    • India
    • China
    • Taiwan
    • Singapore
    • Japan
    • North Korea
    • South Korea
  • Africa
  • Western Europe
    • European union
    • Germany
    • Italy
    • United Kingdom
    • France
  • Eastern Europe
    • Czechia
    • Slovakia
    • Poland
    • Hungary
    • Romania
    • Ukraine
  • America
  • Finance
    • Gold
    • Global Debt
    • BRICS
    • World Economic Forum
  • Technology
    • Amazon
    • Starbucks
    • Tesla
    • Nvidia
    • Instagram
    • Meta
    • Microsoft
    • Google
    • ChatGPT
    • Artificial Intelligence
    • Apple
    • Transhumanism
  • Australia
  • Eastern Europe / European union / Western Europe

Leqembi® (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s …

by Editor · April 16, 2025

… European Union. Leqembi® (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union …Read More

Related posts:

  1. Leqembi®∇ (lecanemab) is the First Medicine that Slows – GlobeNewswire
  2. Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union
  3. Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union
  4. Eisai Gets Positive Opinion From CHMP In European Union For Lecanemab In Early … – Nasdaq
  5. Update on regulatory review of lecanemab for treatment of early Alzheimer’s disease in the …
  • Next story Leqembi®∇ (lecanemab) is the First Medicine that Slows – GlobeNewswire
  • Previous story Renewed concern over direction of EU climate policy in wake of alarming 2024 weather report

RSS BBC World News feed

  • Emotional send-off for Kenya's revered ex-PM Raila Odinga at state funeral
  • Can Putin's 'Flying Kremlin' travel through EU airspace to Budapest?
  • Bolton pleads not guilty to charges of sharing classified information

RSS Sky World News feed

  • Family of Mango founder say his son played no part in his fatal cliff fall amid investigation
  • Italian anti-mafia police investigating explosion of journalist's car
  • Videos show fresh evidence of Israeli support for Gaza militia

RSS Al Jazeera News feed

  • Gaza aid deliveries still facing Israeli roadblocks a week into ceasefire
  • Madagascar’s Randrianirina promises ‘profound change’
  • Will Madagascar’s coup overshadow its Gen Z revolution?

RSS Iran News

  • Gaza needs to heal and rebuild
  • Iran open to talks but won’t give in to excessive demands
  • Iran’s Villages Beacons of Cultural Sustainability

GeoPolitics Pulse © 2025. All Rights Reserved.

Powered by  - Designed with the Go Hueman Pro